Receptor activator of nuclear factor kappa B ligand (RANKL) levels in peri-implant crevicular fluid

Iranian Journal of Immunology

Volumn 7, Issue 4, 2010, Pages 226-233

  Sarlati, Fatemeh ^a   Sattari, Mandana ^b   Gazar, Ali Ghorbani ^a   Rafsenjani, Ali Nabavizadeh ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Crevicular fluid; ELISA; RANKL

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGIVITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIIMPLANTITIS; STOMATITIS; TOOTH IMPLANTATION;

EID: 79952661129     PISSN: 17351383     EISSN: 1735367X     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Jemt T, Lekholm U, Adell R. Osseointegrated implants in the treatment of partially edentulous jaws: A preliminary study on876 consecutively placed fixtures. Int Oral Maxillofac Implants. 1989; 4:211-17.
2. Jemt T, Lekholm U. Oral implant treatment in posterior partially edentulous jaws: A five-year follow-up report. Int Oral Maxillofac Implants. 1993; 8:635-40.
3. Lekholm U, Gunne J, Henry P, Higuchi K, Lindén U, Bergström C,et al.Survival of the Brånemark implant in partially edentulous jaws: a 10-year prospective multicenter study. Int J Oral Maxillofac Implants. 1999; 14:639-45
4. Nevins M, Langer B. The successful application of osseointegrated implants to the posterior jaw: A long-term retrospective study. Int J Oral Maxillofac Implants. 1993; 8: 428-32.
5. Alberktsson T, Johansson CB, Sennerby L.Biological aspects of implant dentistry: osseeointegration. Periodontol 2000. 1994; 4:58-73.
6. Albrektsson T, Zarb G, Worthington P, Eriksson AR. The long-term efficacy of currently used dental implants: A review and proposed criteria of success. Int Oral Maxillofac Implants. 1986; 1:11-25.
7. Gualini F, Berglundh T. Immunohistochemical characteristics of inflammatory lesions at implants. J Clin Periodontol. 2003; 30:14-8.
8. Crotti TN, Ahern MJ, Lange K, Weedon H, Coleman M, Roberts-thomson PJ, et al. Variability of RANKL and osteoprotegerin staining in synovial tissue from patients with active rheumatoid arthritis: quantification using color video image analysis. J Rheumatol. 2003; 30:2319-24.
9. Teitelbaum SL. Bone resorption by osteoclasts. Science. 2000; 289:1504-8.
10. Lerner UH. Inflammation-induced bone remodeling in periodontal disease and the influence of post-menopausal osteoporosis. J Dent Res. 2006; 85:596-607.
11. Haynes DR, Crotti TN, Zreiqat H. Regulation of osteoclast activity in peri-implant tissues. Biomaterials. 2004; 25:4877-85.
12. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, et al. Ossteoclast differentiation factor is a ligand for osteoprotegerin/osteoclast inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA. 1998; 95:3597-602.
13. Takayanagi H, Iizika H, Juji T, Nakagava T, Yamamoto A, Miyazaki T, et al. Involvement of receptor activator of nuclear factor kappa B ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum. 2000; 43:259-69.
14. Kotake S, Udagawa N, Hakoda M, Mogi M, Yano K, Tsuda E, et al. Activated human T cells directly induce osteoclastogenesis from human monocytes. Arthritis Rheum. 2001; 44: 1003-12.
15. Taubman MA, Valverde P, Han X, Kawai T. Immune response: the key to bone resorption in periodontal disease. J Periodontol. 2005; 76:2033-41.
16. Crotti TN, Smith MD, Findlay DM, Zreiqat H, Ahern MJ, Weedon H, et al. Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: expression of receptor activator NFkappaB, RANK ligand and osteoprotegerin. Biomaterials. 2004; 25:565-73.
17. Mogi M, Otogoto N, Ota N, Togari A. Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis. J Dent Res. 2004; 83:166-9.
18. Lu H-K, Chen Y-L, Chang H-C, Li C-L, Kuo MY. Identification of the OPG/RANKL system in gingival crevicular fluid and tissue of patients with chronic periodontitis. J Periodont Res. 2006; 41:354-60.
19. Griffiths GS. Formation, Collection and significance of gingival crevice fluid. Periodontol 2000. 2003; 31:32-42.
20. Monov G, Strbac GD, Baron M, Kandler B, Watzek G, Gruber R. Soluble RANKL in crevicular fluid of dental implants: a pilot study. Clin implant Dent Relat Res. 2006; 8:135-41.
21. Arikan F, Buduneli N, Kutukculer N. Osteoprotegerin levels in peri-implant crevicular fluid. Clin Oral Implants Res. 2008; 19:283-8.
22. Duarte PM, de Mendoca AC, Máximo MB, Santos VR, Bastos MF, Nociti Júnior FH. Differential cytokine expressions affect the severity of peri-implant disease. Clin Oral Implants Res. 2009; 20:514-20.
23. Silness J, Loe I. Periodontal disease in pregnancy. ll. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand. 1964; 22:121-35.
24. Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J. 1975; 25:229-35.
25. Loe H, Silness J. Periodontal disease in pregnancy 1.Prevalence and severity. Acta Odontol Scand. 1963; 21:533-51.
26. Luterbacher S, Mayfield L, Bragger U, Lang NP. Diagnostic characteristics of clinical and microbiological tests for monitoring periodontal and peri-implant mucosal tissue conditions during supportive periodontal therapy (SPT). Clin Oral Implants Res. 2000; 11:521-9.
27. Buser D, Weber HP, Lang NP. Tissue integration of non-submerged implants. 1-year results of a prospective study with 100 ITI hollow-cylinder and hollow-screw implants. Clin Oral Implants Res 1990; 1: 33-40.
28. Vernal R, Chaparro A, Graumann R, Puente J, Valenzuela MA, Gamonal J. Levels of cytokine receptor activator of nuclear factor KB ligand in gingival crevicular fluid in untreated chronic periodontitis patients. J Periodontol. 2004; 75:1586-91.
29. Bragger U, Burgin W, Hammerle CHF, Lang NP. Associations between clinical parameters assessed aroung implants and teeth. Clin Oral Implants Res. 1997; 8:412-21.
30. Bostanci N, Ilgenli T, Emingil G, Afacan B, Han B, Toz H, et al. Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio. J Clin Periodontol. 2007; 34:367-9.
31. Nakashima T, Kobayashi Y, Yamasaki S, Kawakami A, Eguch K, Sasaki H, et al. Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappa B ligand: modulation of the expression by osteotropic factors and cytokines. Biochem Biophys Res Commun. 2000; 275:768-75.
32. Sabokbar A, Kudo O, Athanasou NA. Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis. J Orthop Res. 2003; 21:73-80.
33. Kudo O, Sabokbar A, Pocock A, Itonaga I, Fujikawa Y, Athanasou NA. Interleukin-6 and Interleukin-11 support human osteoclast formation by a RANKL- independent mechanism. Bone. 2003; 32:1-7.